Results 251 to 260 of about 9,392,573 (389)

State-specific inhibition of NMDA receptors by memantine provides insight into NMDAR channel blocker tolerability. [PDF]

Sci Adv
Phillips MB, Povysheva NV, Neureiter EG, Nigam A, Harnett-Scott KA, Hell JW, Aizenman E, Johnson JW.   +7 more
europepmc   +1 more source

The relationship between a developmental theory of brain hemisphere lateralization and age and sex differences in field dependence-independence and visuo-spatial measures /

, 1978
Donna F. Berlin
openalex   +1 more source

Measuring the Column Dependence of Read Noise in ACS/WFC Bias Frames

Alyssa M. Guzman, Meaghan C. McDonald
openalex   +1 more source

Benchmarking Dependence Measures to Prevent Shortcut Learning in Medical Imaging [PDF]

Sarah Müller, Louisa Fay, Lisa M. Koch, Sergios Gatidis, Thomas Küstner, Philipp Berens   +5 more
openalex   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

Molecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel, Izabela Kubiak, Lena Rutkowska, Żaneta Kasprzyk, Łukasz Kępczyński, Michał Bednarek, Dariusz Sobieraj, Jacek Wilkosz, Piotr Kania, Adam Jędrzejczyk, Bogdan Kałużewski, Agnieszka Gach, Tadeusz Kałużewski   +12 more
wiley   +1 more source

Cannabis Use Disorder in the Era of Legalization: Implications for Addiction Treatment Systems. [PDF]

Subst Abuse Rehabil
Bahji A.
europepmc   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Towards precision EEG connectomics: Evaluating the benefits of dense sampling. [PDF]

Imaging Neurosci (Camb)
Graff K, Rai S, Yin S, Godfrey KJ, Merrikh D, Tansey R, Vanderwal T, Protzner AB, Bray S.   +8 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Application of contrast-enhanced CT-based radiomics with machine learning to predict WHO/ISUP grading in clear cell renal cell carcinoma. [PDF]

BMC Cancer
Li X, Song S, Ge W, Wang H, Liu W, Qi X, Zhao Y.   +6 more
europepmc   +1 more source